December 07, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Vascular Solutions, Inc. (NASDAQ:VASC), was announced concerning whether the takeover of Vascular Solutions, Inc. by Teleflex Incorporated for $56.00 per share is unfair to NASDAQ:VASC stockholders.

The investigation by a law firm concerns whether certain officers and directors of Vascular Solutions, Inc. breached their fiduciary duties owed to NASDAQ:VASC investors in connection with the proposed acquisition.

On December 2, 2016, Vascular Solutions, Inc. (Nasdaq: VASC) announced that it has entered into an agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56.00 per share in cash.

However, given that at least one analyst has set the high target ofr NASDAQ:VASC shares at $58.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:VASC stockholders. More specifically, the investigation concerns whether the Vascular Solutions Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Shares of Vascular Solutions, Inc. (NASDAQ:VASC) closed on December 7, 2016 at $56.00 per share.